We facilitate fully-resourced studies to ensure successful health research for you and your patients
We fully fund all resources required to successfully deliver Genuity Science clinical studies at a local level. Our studies minimize disruption to your clinic and participation for any volunteer involves only a single appointment with a short questionnaire, a blood draw and a physical assessment. When required, we provide trained staff to support delivery of this service.
Our Partnership Model
Why Collaborate with Genuity Science
Data Enrichment
Data Enrichment
Return of high-quality multi-omic research datasets generated in CAP accredited facility with secure and GDPR-compliant research dataset management
Research Empowerment
Research Empowerment
Returned datasets can be used in academic research and publications also assisting preparation of funding applications with Genuity Science as an industry partner
Bioresource Development
Bioresource Development
Support in development of new bioresources, expansion of existing resources or launching of prospective studies with operational, financial and technical
support
Technical Expertise
Technical Expertise
Access to technical expertise and analytical support from our cross-functional team including; Bioinformaticians & Genomic Analysts, IT & AI experts, Clinical Researchers, Project Managers and Legal, Ethics & Privacy Experts
Data Enrichment
Research Empowerment
Bioresource Development
Technical Expertise
Genuity Science working in partnership with Nashville Biosciences
The agreement provides use of extensive real world clinical data and clinical research samples across multiple high priority disease areas.
The HeartBeat Trust is an Irish charity supporting specialist clinical and research services in heart failure and its prevention in Ireland. The Trust supports a screening programme service called STOP-HF which is aimed at the early detection and prevention of heart failure. Genuity Science and the HeartBeat Trust have collaborated in a research programme to discover more about how genomics and multi-omics influence heart failure and the progression of the patient through the various stages. We aim to identify biomarkers of progression and prevention that will lead to new diagnostic tools and new therapeutics, especially in subtypes of heart failure where there are none.
Modality Partnership
The largest primary care group in the UK Modality Partnerships have collaborated with Genuity Science on our complex disease studies. The focus is on specific medical conditions where there is an indication of a genetic or inherited link to the condition. Whole genome sequencing (WGS) will be performed to allow us to better understand the genetic variants that influence disease risk, effects and treatment.
Hospital, Academic and Clinical Research Centers (Ireland)
Emory University (US)
Nashville Biosciences (US)
Primary Care Centers (UK)
University of Cambridge (UK)
University of Massachusetts Medical Center (US)
University of Southern California (US)
Vanderbilt University Medical Center
Yale University Medical Center (US)
This website stores cookies on your computer. Some of these cookies enable this website to function and some of these cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy and Privacy Policy.
